Posts

Investment on Power Sector in Summer Season is Good or Not?

Image
Investment on Power Sector in Summer Season is Good or Not? India power generation including renewable resources       is 1381.82(bu) in 2020-2021 and 1389.10(bu) in 2019-2020 respectively. Current year till January-2022 is 1234.29(BU) up by 8.48% from past year. Current year Peak demand is 2,03,014 (MW) , demand met is 2,00,539 (MW) and deficit is -2,475 (-1.2%) . Power Consumption grows every year from March to August. Now its best opportunity to buy power stocks. -         Figure showing Power Consumption in India month on month As Power consumption is growing rapidly in India and a paradigm shifting in EV sector, we may see significant rise in stocks which are somewhere associated with Power Sector in India. Analyses of some of these companies and there performance over the year is provided below:- -         IEX has given 124% return over the year. -         Tata Power has given 157% return over the year. -
Post a Comment
Read more

It’s Right Time to Invest in IT Sector?

Image
  The last two weeks were not good for Indian Market.   FII sold more than 34,800 crore shares in last two week and DII bought only 11,300 crore shares,due to this selling Nifty and Sensex fall 6.47 % and 6.73% respectively. This fall also reported in NIFTY IT and Other Indexes.   Nifty IT was down by 13.52% in just 9 trading session from 17 th January to 27 th January.     Let’s talk about Nifty IT Indices Date Price Open High Low Volume Chg% Jan 28, 2022 33,851.95 33,608.45 34,473.50 33,608.45 48.31M 1.13% Jan 27, 2022 33,475.05 34,338.10 34,362.85 33,251.70 49.32M -3.55% Jan 25, 2022 34,707.45 34,490.35 35,065.80 33,956.55 41.91M -0.33% Jan 24, 2022 34,821.60 35,934.20 35,9
Post a Comment
Read more

Is Glenmark Life Science Good Bet for Long-Term Investment?

Image
    Market Price: - 733.85 Glenmark Life Science list at 751 with just 4% premium on Indian Stock Exchange as on 06 August 2021. Glenmark Life Sciences initial public offering had received strong response from investors as the offer was subscribed 44.17 times during July 27-29, 2021. The Non-institutional investors reserved portion was subscribed 122.54 times, the qualified institutional buyers were subscribed 36.97 times and the retail portion received 14.63 times subscription. Due to downtrend in Pharma Sector, Glenmark Life Science listed at Just 4% Premium after getting good subscription.     Glenmark Life Science Limited Glenmark Life Sciences is an API arm of Glen Mark Pharma, a leading drug maker. They are one of the leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs).   Who They Are? They are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, they have established strong relationship
4 comments
Read more